27963
蓖麻油，乙氧基化
别名:
Cremophor® EL, PEG-35蓖麻油, 乙氧基化蓖麻油, 聚甲醛-35蓖麻油
InChI
1S/C4H7Cl2NO2/c5-1-3(2-6)9-4(7)8/h3H,1-2H2,(H2,7,8)
InChI key
JMNCUXPHXKHBPY-UHFFFAOYSA-N
description
non-ionic
density
1.05 g/mL at 20 °C
application(s)
sample preservation
正在寻找类似产品? 访问 产品对比指南
Other Notes
是蓖麻油和环氧乙烷的一种衍生物。
This product has been replaced by C5135-SIGMA | Kolliphor EL pH-range 6.0 - 8.0
Legal Information
Cremophor is a registered trademark of BASF SE
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
494.6 °F - Not applicable
flash_point_c
257 °C - Not applicable
ppe
Eyeshields, Gloves
法规信息
新产品
此项目有
Masafumi Uematsu et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 27(5), 437-444 (2011-07-01)
To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method to evaluate acute corneal barrier dysfunction induced by travoprost Z with sofZia (Travatan Z(®)), travoprost with 0.015% BAC (Travatan(®)), and its additives. Corneal transepithelial
Shoukath M Ali et al.
International immunopharmacology, 10(3), 325-330 (2009-12-23)
Develop Nanosomal formulation of Tacrolimus to provide safer alternative treatment for organ transplantation patients. Investigate safety, tolerability and pharmacokinetics of Nanosomal Tacrolimus formulation versus marketed Tacrolimus containing polyoxyl 60 hydrogenated castor oil (HCO-60) that causes side effects. Nanosomal Tacrolimus was
Eiki Goto et al.
Ophthalmology, 109(11), 2030-2035 (2002-11-05)
We developed low-concentration homogenized castor oil eye drops for the treatment of patients with noninflamed obstructive meibomian gland dysfunction (MGD), a major cause of lipid-deficiency dry eye, and assessed the safety, stability, and efficacy of the eye drops. Randomized, double-masked
Shu Yu et al.
Vaccine, 30(36), 5425-5436 (2012-06-20)
Oil-in-water emulsions are potent human adjuvants commonly used in effective pandemic influenza vaccines; however, such emulsions that can induce both Th1-biased systemic immune responses and strong mucosal immune responses via an easy method of administration are lacking. To address this
Yukako Ito et al.
Journal of drug targeting, 13(6), 383-390 (2005-11-10)
Interferon alpha (IFN-alpha), patch preparations composed of three layers, water-insoluble backing layer, drug containing layer with absorption enhancer and surface layer containing pH-dependent polymer were prepared. As absorption enhancer, three surfactants, Gelucire44/14 (Lauroyl macrogol-32 glycerides), Labrasol (Caprylocaproyl macrogol-8 glycerides) and
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持